Author

Ina Møller

Observed name: Møller, Ina

Institution: Norwegian University of Science and Technology

Observed institutions: Norwegian University of Science and Technology, St Olav's University Hospital

OpenAlex ID: A5090015751

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

2018 · for the Dominantly Inherited Alzheimer Network (DIAN), Daniel Twohig, et al. · Acta Neuropathologica Communications · 68

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease

2018 · Kalicharan Patra, Antoninus Soosaipillai, et al. · Alzheimer s Research & Therapy · 42

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study

2016 · Guro Berge, Sigrid B. Sando, et al. · BMC Neurology · 28

Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42

2017 · Camilla Lauridsen, Sigrid B. Sando, et al. · Frontiers in Aging Neuroscience · 26

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease

2017 · Ina S. Almdahl, Camilla Lauridsen, et al. · Frontiers in Aging Neuroscience · 26

Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer’s Disease, Mild Cognitive Impairment, or Healthy Control Individuals

2015 · Guro Berge, Camilla Lauridsen, et al. · Journal of Alzheimer s Disease · 14

Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study

2016 · Camilla Lauridsen, Sigrid B. Sando, et al. · Frontiers in Aging Neuroscience · 13

Supervised clinical placement and case-based learning

2026 · Else-Berit Stenseth, Runa Berg Østby, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Additional file 1: Table S1. of Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study

2016 · Berge, Guro, Sando, Sigrid, et al. · Figshare

Additional file 2: Table S2. of Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study

2016 · Berge, Guro, Sando, Sigrid, et al. · Figshare

P3‐035: Mitogen‐activated Protein Kinases in Lysates of Polymorphonuclear Leukocytes From Patients With Alzheimer's Disease and Mild Cognitive Impairment

2014 · Camilla Lauridsen, Sigrid Botne Sando, et al. · Alzheimer s & Dementia

Works count: 15

Citation count: 217

H-index: 7

I10-index: 7